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et al., 1994). Occupancy of the IL-4 receptor inducesand Achsah D. Keegan*
tyrosine phosphorylation of the 170 kDa protein, 4PS,*Immunology Department
and of IL-4Ra (Wang et al., 1992; Izuhara and Harada,Jerome Holland Laboratories
1993). 4PS is related to insulin receptor substrate-1American Red Cross
(IRS-1), a substrate of the insulin receptor kinase (Wang15601 Crabbs Branch Way
et al., 1993a), and also serves as a substrate for theRockville, Maryland 20855
insulin and insulin-like growth factor-1 (IGF-1) receptors.²Laboratory of Immunology
IRS-1 contains more than 20 potential tyrosine phos-National Institute of Allergy and Infectious Diseases
phorylation sites and 30 potential serine/threonine phos-National Institutes of Health
phorylation sites (White and Kahn, 1994). The cDNA en-Bethesda, Maryland 20892
coding 4PS has recently been cloned from the myeloid
cell type FDC-P2 (Sun et al., 1995). The sequence for
4PS is not highly homologous to IRS-1, but it containsSummary
tyrosine phosphorylation sites similar to IRS-1. The
designation IRS-2 has been proposed. Tyrosine-phos-
IL-4 binds to a cell surface receptor complex that con-
phorylated sites within IRS-1 and 4PS/IRS-2 associate
sists of the IL-4-binding protein (IL-4Ra) and the g with high affinity to cellular proteins that contain
chain of the IL-2 receptor complex (gc). The receptors SH2 domains, including the p85 subunit of PI-3-kinase
for IL-4 and IL-2 have several features in common; (PI-3-K), growth factor receptor±bound protein 2
both use the gc as a receptor component, and both (GRB2), the SH2 and SH3 domain containing adaptor
activate the Janus kinases JAK-1 and JAK-3. In spite protein nck, and the src-homology protein tyrosine
of these similarities, IL-4 evokes specific responses, phosphatase 2 (White and Kahn, 1994).
including the tyrosine phosphorylation of 4PS/IRS-2 Using the myeloid progenitor cell line 32D-IRS-1
and the induction of CD23. To determine whether that expresses the cDNA for rat (r)IRS-1 (Wang et al.,
sequences within the cytoplasmic domain of the IL- 1993b), we identified a region of human (hu)IL-4Ra, be-
4Ra specify these IL-4-specific responses, we trans- tween amino acids 437 and 557 that is important for
planted the insulin IL-4 receptor motif (I4R motif) of IL-4-induced cell growth and IRS-1 phosphorylation
the huIL-4Ra to the cytoplasmic domain of a truncated (Keegan et al., 1994a, 1994b). This interval contains a
IL-2Rb. In addition, we transplanted a region that con- single Y residue surrounded by a sequence motif
tains peptide sequences shown to block Stat6 binding (491PLXXXXNPXYXSXSD505) that is homologous to se-
to DNA. We analyzed the ability of cells expressing quences found in the insulin and IGF-1 receptors. This
these IL-2R±IL-4R chimeric constructs to respond to motif has been designated the insulin±IL-4 receptor mo-
tif (I4R motif). Mutation of the central Y residue of theIL-2. We found that IL-4 function could be transplanted
I4R motif to an F in the huIL-4Ra (Keegan et al., 1994a)to the IL-2 receptor by these regions and that prolifera-
or the human insulin receptor (White et al., 1988) impairstive and differentiative functions can be induced by
the ability of these receptors to signal IRS-1 phosphory-different receptor sequences.
lation or to induce a proliferative response upon occu-
pancy by their cognate ligand, demonstrating that theIntroduction
Y residue in the I4R motif is important for linking to
the IRS-1 pathway in both the IL-4 and insulin receptorTreatment of cells with interleukin-4 (IL-4) elicits many
systems. The I4R motif has been proposed to be andifferent biological responses, including an increase in
IRS-1 docking site. Indeed, a direct interaction between
cell proliferation and the transcription of a series of
IRS-1 and the I4R motif of the insulin receptor (O'Neill
genes, particularly those involved in B cell differentiation
et al., 1994) and the huIL-4Ra (K. Nelms and W. E. P.,
(Paul, 1991). Some of these responses are unique to unpublished data) has been demonstrated using the
IL-4, while others are also elicited by different cytokines. yeast two-hybrid system.
These responses aremediated by the IL-4 receptor com- Information on the signaling mechanisms that the IL-4
plex, which consists of a 140 kDa high affinity binding receptor may use for the activation of gene expression
chain (IL-4Ra) (Idzerda et al., 1990; Galizzi et al., 1990) has been obtained. Engagement of cytokine receptors
and the common g chain (gc) (Russell, et al., 1993; can lead directly to the rapid tyrosine phosphorylation
Kondo, et al., 1993) that is shared by the receptors for and nuclear translocation of factors involved in gene
IL-2, IL-7, IL-9, and IL-15 (Takeshita et al., 1992; Noguchi transcription, termed signal transducers and activators
et al., 1993; Kondo et al., 1994; Russell et al., 1994; Giri of transcription (STATs) (Darnell et al., 1994). Recent
et al., 1994). Both chains of the IL-4 receptor complex work has demonstrated that a factor related to the
are members of the hematopoietin receptor superfamily known STATs may be involved in the signaling pathway
(Cosman, 1993). Like other members of this family, the from the IL-4 receptor complex to the nucleus. Three
IL-4 receptor does not contain any consensus se- groups initially identified a factor that is tyrosine phos-
quences encoding tyrosine or serine/threonine kinases. phorylated by IL-4 and that binds to consensus
However, it has been shown that IL-4Ra associates with sequences found within the promoter regions of IL-4-
inducible genes (Kohler and Rieber, 1993; Kotanidesthe Janus family kinase JAK-1 (Yin et al., 1994) and the
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and Reich, 1993; Schindler et al., 1994). The cDNA for
an IL-4-inducible DNA-binding factor has been cloned,
found to be related to the STAT family, and designated
IL-4±STAT or Stat6 (Hou et al., 1994; Quelle et al., 1995).
Interestingly, it was found that tyrosine-phosphorylated
peptides derived from the sequence of a region of the
huIL-4Ra cytoplasmic domain downstream of the I4R
motif could inhibit the ability of Stat6 to bind DNA in
vitro (Hou et al., 1994). Recent evidence suggests that
complete activation of DNA binding by STATs may de-
pend on a serine/threonine kinase (Zhang et al., 1995;
Boulton et al., 1995; Wen et al., 1995).
Although the receptors for IL-4 and IL-2 have several
features in common, including their use of the gc as a
receptor component, and their activation of JAK-1 and
JAK-3 (Witthuhn et al., 1994; Johnston et al., 1994), IL-4
evokes responses that IL-2 does not, such as the tyro-
sine phosphorylation of 4PS in murine cells (Morla et
Figure 1. Map of Chimeric Receptorsal., 1988), activation of Stat6 (Quelle et al., 1995; Lin et
The extracellular (EX), transmembrane (TM), and cytoplasmic do-al., 1995), and induction of a set of genes (i.e., CD23,
mains of the huIL-4R (shaded) and truncated huIL-2Rb (open) areclass II molecules, and the germline transcripts of the
shown. The Y residue within the I4R motif (amino acids 439±555,
g1 and e immunoglobulin heavy chain genes). We pro- lightly shaded) is marked with the arrow, and the Y residues in the
pose that sequences within the cytoplasmic domain of amino acid 558±657 domain (hatched) demonstrated to block a
Stat6-mediated electrophoretic mobility shift are marked with aster-the IL-4Ra determine the IL-4-specific responses and
isks. These domains were fused to a truncated huIL-2Rb in wild-that the region containing such sequences can act as
type and mutant form as indicated.a domain capable of functioning in other settings.
Our previous studies in the 32D cell line have demon-
1994). The IL-2Rb truncation is similar to theH truncationstrated that the I4R motifplays a crucial role in regulating
initially described by Hatakeyama et al. (1989) and isproliferation, while the presumed Stat6 docking motifs
competent to stimulate tyrosine phosphorylation (Tani-are largely dispensible for proliferation (Keegan et al.,
guchi and Minami, 1993; data not shown) and to associ-1994a; Quelle et al., 1995; Pernis et al., 1995). Stahl et
ate with JAK-1 (Miyazaki et al., 1994), but lacks theal. (1995) has shown that a 5 aa Stat3-binding motif
tyrosine residues needed to recruit Stat5 (Lin et al.,derived from the cytoplasmic domain of gp130 was suffi-
1995; Fujii et al., 1995). The chimeric constructs werecient to direct the tyrosine phosphorylation of Stat3 in
transfected into 32D-IRS-1 cells or the B cell lymphoma,the context of the erythropoietin receptor cytoplasmic
M12.4.1. All the lines demonstrated similar levels of IL-domain. However, they did not address whether the
2Rb expression when analyzed by FACS staining usingStat3-binding motif had any effect on the activation of
anti-huIL-2Rb (Figure 2).specific genes by cyokines that utilize gp130 as a recep-
We analyzed the ability of the transfected 32D-IRS-1tor component or on any gp130-dependent biological
lines to proliferate in response to IL-2 (Figure 3). In a 3response. Herein, we examine the ability of sequences
day proliferation assay, IL-2 caused little growth of cellderived from the huIL-4Ra to dictate IL-4-specific
lines expressing the IL-2Rb construct truncated atbiologic and biochemical responses in two different
amino acid 378 (TRUNC) (Figure 3A), a result similarmodel systems. We transplanted tyrosine-containing
to that reported by Goldsmith et al. (1994). Cell linessequences from the huIL-4Ra cytoplasmic domain, in-
expressing chimeric receptors that include the domaincluding the I4R motif and the presumed Stat6 docking
containing the I4R motif alone (CHIM-1) proliferated inmotifs, to the cytoplasmic domain of a truncated human
response to IL-2, while the chimeric receptor lackingIL-2Rb. We found that IL-4-specific biological function
the I4R-containing domain (CHIM-2) did not (Figure 3B).could indeed be transplanted to the IL-2 receptor by
An unexpected finding was that cell lines expressingthese regions and that proliferative and differentiative
CHIM-1 showed greater tritiated thymidine uptake infunctions could be transplanted by different receptor
response to various concentrations of IL-2 than did linessequences.
expressing CHIM-3 (Figures 3B and 3C). Since CHIM-3
is comprised of both the I4R-containing domain and theResults
domain comprised of amino acids 558±657, this result
suggests that the region between amino acids 558±657To determine whether IL-4-specific signals could beme-
contains a negative regulator of the function of the I4Rdiated by regions of the IL-4 receptor, we ªtransplantedº
motif or of cell growth. The importance of the Y in the I4Rtwo domains of the huIL-4Ra to a truncation of the IL-
motif is shown by the finding that cell lines expressing2Rb chain (Figure 1). These domains contain tyrosine
chimeric receptors with Y to F mutations in the I4R motifresidues shown to be important for eliciting either a
(CHIM-1Y497F and CHIM-3Y497F ) showed marked im-proliferative response (amino aacids 439±555, con-
pairment in IL-2-induced proliferation (Figure 3B). Alltaining the I4R motif) (Keegan et al., 1994a) or the induc-
the cell lines responded vigorously to IL-3 and they alltion of DNA-binding activity (amino acids 558±657, con-
taining two peptides shown to bind to Stat6) (Hou et al., responded to mIL-4 in a short term (24 hr) assay (Figure
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Figure 2. Levels of huIL-2Rb Expression
Expression of the chimeric constructs was
determined by staining with anti-huIL-2Rb as
described in Experimental Procedures. Cells
were stained in the presence (solid line) or
absence (dotted line) of the first antibody.
3D) as expected (Wang et al., 1993b; Keegan et al., 0.125, 2.18, 2.3; 0.15, 2.26, 0.13). Thus, the addition
of IL-4R sequence containing the wild-type I4R motif1994a).
We also analyzed the ability of the chimeras to stimu- confers the ability of the truncated IL-2Rb to signal an
enhanced proliferative response that is correlated withlate the tyrosine phosphorylation of IRS-1 and its associ-
ation with the SH2 domain±containing molecules PI-3-K the association of IRS-1 with GRB2.
To determine the ability of huIL-4Ra sequences toand GRB2 (Figure 4). The 32D-IRS-1 lines demonstrated
some constitutive tyrosine phosphorylation of IRS-1, as confer differentiation functions, we analyzed the capac-
ity of the chimeric IL-2 receptors to induce IL-4-specificshown by direct anti-phosphotyrosine blots of cell ly-
sates (Figure 4A) and of anti-IRS-1 immunoprecipitates responses in the B cell lymphoma, M12.4.1. The trans-
fectant expressing TRUNC did not demonstrate any IL-of the parental 32D-IRS-1 cell line (Figure 4B) and by
the constitutive association of IRS-1 with p85 (Figure 2-induced tyrosine phosphorylation of 4PS as detected
by precipitation with anti-phosphotyrosine or an anti-4C). However, we found that stimulation of wild-type
CHIM-1- or CHIM-3-expressing lines with IL-2, but not IRS-1 antisera capable of reacting with 4PS followed by
anti-phosphotyrosine blotting (Figure 5). The ability toTRUNC- or CHIM-2-expressing lines, induced the asso-
ciation of IRS-1 with GRB2 (Figure 4C). Since IRS-1 signal the tyrosine phosphorylation of 4PS correlated
with the expression of a wild-type I4R motif (CHIM-1posseses only one consensus site for GRB2 binding
(Y895VNI), and the interaction of IRS-1 with GRB2 is de- and CHIM-3); chimeras with Y497F showed greatly di-
minished IL-2-induced phosphorylation of 4PS (densito-pendent on tyrosine phosphorylation (White and Kahn,
1994), these results suggest that the IRS-1 residue in- metric analysis of band intensities of anti-IRS-1 pre-
cipitates for CHIM-1 or CHIM-1Y497F stimulated withvolved in GRB2 binding is not constitutively phosphory-
lated in these cells, but that its phosphorylation is stimu- nothing, IL-4, or IL-2 were as follows: 0.0, 14.8, 7.0;
0.0, 15.0, 0.0 arbitrary units and, for CHIM-3 or CHIM-ated by signaling through the I4R motif of the huIL-4Ra.
CHIM-1 or CHIM-3 expressing the Y497F mutation were 3Y497F: 0.0,13.2, 9.4; 0.0, 10.7, 1.2). CHIM-2, lacking
the I4R motif, had no activity in this assay. These resultsdeficient at stimulating association of IRS-1 with GRB2
in response to IL-2 (densitometric analysis of band inten- demonstrate that Y497 and its surrounding sequence
can convey this IL-4 function to the IL-2 receptor.sities for CHIM-1 or CHIM-1Y497F stimulated with noth-
ing, IL-4, or IL-2 were as follows: 0.11, 2.0, 2.5; 0.1, 2.38, We found that the capacity to induce the expression
of CD23 could also be conferred on the IL-2 receptor0.3 arbitrary units and, for CHIM-3 or CHIM-3Y497F:
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series of independent stable B lymphoma lines express-
ing transfected receptors. The degree of receptor ex-
pression by CHIM-3-Y497F lines was comparable to
those expressed by the other stable transfectants. This
indicates that the Y497F mutation results in a strong
negative regulation of CD23 induction and confirms the
concept of cross-domain regulation already noted by
the greater degree of IL-2-induced proliferation of 32D-
IRS-1 cells expressing CHIM-1 than those expressing
CHIM-3.
Discussion
One of the features of cytokine biology is the great
amount of pleiotropy and redundancy that exists among
the cytokines. This occurs both at the functional level
and at the biochemical level. The hematopoietin recep-
tors that utilize the gc as part of their receptor complex
(IL-2, IL-4, IL-7, IL-9, IL-15) share receptor subunits and
basic signalingelements, such as the activation of Janus
family tyrosine kinases and STAT family members. Yet
each of these cytokines has the capacity to elicit a very
specific set of biologic responses. Therefore, a major
question is how do these different receptors, using manyFigure 3. Proliferation of 32D-IRS-1 Cells in Response to IL-2
common elements, signal specific sets of events. The(A) 32D-IRS-1 cells expressing wild-type (circles) or truncated
concept has now emerged that specific sequences in(squares) huIL-2Rb were incubated for 72 hr in the presence of
the cytoplasmic domains of receptors recruit uniquevarious amounts of IL-2. [3H]thymidine was added during the last 5
hr of culture. Two clones are shown for each construct and each sets of signaling molecules to the activated receptor
point represents the mean of triplicate wells. complex (reviewed by Ivashkiv, 1995). In this study, we
(B) 32D-IRS-1 cells expressing the indicated constructs of huIL- have examined the ability of sequences derived from
2Rb were incubated for 72 hr in the presence of 100 U/ml of IL-2.
the huIL-4Ra to dictate IL-4-specific biologic and bio-[3H]thymidine was added during the last 5 hr of culture. Two clones
chemical responses in two different model systems.are shown for each construct and each point represents the mean
We analyzed the ability of huIL-4Ra sequences, in theof triplicate wells plus or minus the error expressed as percentage
of coordinate. context of the IL-2Rb that shares a receptor subunit and
(C) As in (B), except that various concentrations of IL-2 were used activates the same Janus kinases as the IL-4 receptor,
to stimulate the clones expressing CHIM-1 (circles) and CHIM-3 todirect a growth response in the 32D-IRS-1 cell system.
(squares).
32D cells express endogenous IL-4 receptors, although(D) As in (B), except the clones were treated with 5% Wehi-3-condi-
they do not proliferate in response to IL-4 and IL-4 doestioned medium as a source of IL-3 for 72 hr (closed circles) or with
not induce detectable tyrosine phosphorylation of 4PS5 ng/ml mIL-4 for 24 hr (open symbols). [3H]thymidine was added
during the last 5 hr of culture. (Wang et al., 1993b). However, expression of the cDNA
encoding rIRS-1 in these cells (32D-IRS-1 cells) in-
creases their mitogenic response to IL-4. In these
transfected cells, IL-4 readily induces the tyrosine phos-by tyrosine containing sequences derived from the huIL-
4Ra chain (Figure 6). Cell lines expressing chimeric re- phorylation of IRS-1.
In the 32D-IRS-1 cells expressing chimeric receptorceptors that include the defined Stat6 binding sites
(CHIM-2 and CHIM-3) showed induction of CD23 by IL-2 constructs, the ability of IL-2 to initiate proliferation cor-
relateswith expression of the domain possessing a wild-that was only slightly less than that induced by mouse
IL-4. Cell lines expressing CHIM-1, which lacks the de- type I4R motif and the association of IRS-1 with GRB-2.
The SH2 domain of GRB2 binds to a sequence of IRS-fined Stat6 binding sites, did show induction of CD23
in response to IL-2, but to a lesser degree than lines 1 (YVNI) containing Y895 (Skolnik et al., 1993). Mutation
of Y895 to F (Y895F) impairs the ability of GRB-2 toexpressing CHIM-2 or CHIM-3. Y497, of the I4R-motif,
appears to be important in this modest induction of associate with IRS-1 in vitro and in vivo. It has been
shown that 32D cells expressing IRS-1Y895F are stillCD23 by CHIM-1, since mutant CHIM-1 (Y497F) showed
no induction of CD23 whatsoever. The ability of IL-2 able to proliferate in response to insulin (Myers et al.,
1994a), suggesting that the formation of IRS-1±GRB2to induce STF-IL-4 activity correlated with the CD23
induction assay (data not shown). complexes is not essential for insulin-stimulated mito-
genesis. However, insulin treatment also activates theDespite the fact that CHIM-3-Y497F contains intact
Stat6 binding sites, lines expressing this chimera show formation of shc±GRB2 complexes and activates the
mitogen-activated protein (MAP) kinases and this path-a marked reduction in CD23 induction in response to
IL-2 when compared with lines expressing either CHIM- way may be responsible for insulin-stimulated mitogen-
esis (Pruett et al., 1995). It has been reported that IL-42 or wild-type CHIM-3. This result was obtained with a
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Figure 4. Ability of IL-4R±IL-2R Chimeras to
Induce Association of IRS-1 with GRB2
Lysates were prepared from the indicated
cells and separated by SDS±PAGE directly
(A) or after precipitation with anti-IRS-1 (B).
These Western blots were probed with anti-
phosphotyrosine. (C) 32D-IRS-1 cells ex-
pressing the indicated IL-2Rb constructs
were treated with nothing, IL-4 (5 ng/ml), or
IL-2 (100 U/ml). Lysates from treated cells
were prepared and precipitated with anti-p85
or anti-GRB2 as indicated. Western blots of
SDS gels were probed with anti-phosphotyr-
osine. The region of the blot containing IRS-
1 is shown.
Figure 5. Ability of Chimeric Receptors to
Signal 4PS Phosphorylation in Response to
IL-2
M12.4.1 cells expressing the indicated con-
structs of IL-2Rb were treated with nothing,
IL-4 (5 ng/ml), or IL-2 (100 U/ml). 4PS phos-
phorylation was detected by immunopre-
cipitation with anti-phosphotyrosine or anti-
IRS-1 followed by Western blotting with anti-
phosphotyrosine. The region of the blot con-
taining 4PS is shown.
does not strongly activate these pathways (Satoh et al., in those expressing CHIM-3. We had made similar ob-
servations in our earlier studies on deletion constructs1991; Welham et al., 1992) and, therefore, the mitogenic
response to IL-4 may be more dependent on the forma- of the huIL-4Ra (Keegan et al., 1994a). On average, 32D-
IRS-1 cells expressing the huIL-4Ra truncated at aminotion of IRS-1±GRB2 complexes. We cannot rule out the
importance of activation of PI-3-K in the mitogenic re- acid 657 proliferated less well than those cells express-
ing a receptor truncated at amino acid 557. These resultssponse to IL-4. We observed a constitutive level of tyro-
sine phosphorylation of IRS-1 and a constitutive associ- suggest that the sequences in the amino acid 558±657
domain may down-regulate the proliferative pathwayation of IRS-1 with the p85 subunit of PI-3-K. However,
there are 9 potential and 3 known sites of interaction activated by the I4R motif.
IL-4-specific differentiation function could also befor PI-3-K (YXXM) in the IRS-1 molecule (White and
Kahn, 1994) and it is possible that the activity of this transplanted to the IL-2 receptor by Y-containing se-
quences. Either the domain containing the I4R motif orenzyme is increased only after binding to specific sites
in the IRS-1 molecule (Myers et al., 1994b). Although the domain containing the defined Stat6 binding site
conveys to the IL-2R theability to induce CD23, althoughthe biochemical basis of IL-4-induced growth is not
completely clear, the activation of the IRS-1 or 4PS path- to differing degrees. Surprisingly, when the two domains
were expressed together, we observed that expressionway can be induced by transferring the domain con-
taining the wild-type I4R motif, confirming our earlier of Y at position 497 of the I4R motif played a critical role
in gene induction, suggesting some complex interactionwork. This is especially clear in the transfected M12.4.1
cells that express physiologic levels of 4PS. between the two domains orbetween the signaling path-
ways they activate. The nature of the interaction is cur-Interestingly, IL-2 caused a consistently greaterprolif-
erative response in cell lines expressing CHIM-1 than rently unknown but could potentially be linked to serine/
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Figure 6. CD23 Induction in Response to IL-2
M12.4.1 cells expressing the indicated con-
structs of IL-2Rb were treated with media
(dashed line), mouse IL-4 (dotted line), or hu-
man IL-2 (solid line) for 48 hr. CD23 induction
was analyzed by FACS using FITC±anti-
CD23. Three individual clones expressing the
various chimeric receptors are shown.
threonine kinase activation (Zhang et al., 1995; Boulton Y497 failed to block binding to DNA. In addition, we did
not observe the tyrosine phosphorylation of Stat6 inet al., 1995; Wen et al., 1995) or perhaps to an increased
activation of a tyrosine phosphatase. Alternatively, it response to huIL-4 in 32D cells expressing the d557
truncation mutant, a construct expressing Y497 (Quellemay reflect a domain±domain interaction, which may
prevent access of substrates. Phosphorylation of key et al., 1995). However, we have observed IL-4-induced
gel shift activity in the d557-expressing 32D cells (Pernistyrosine residues in one or both domains upon receptor
ligation may disrupt the interaction and allow efficient et al., 1995), suggesting that the gel shift assay is more
sensitive than the Western blotting assay.docking of substrate.
Although Y497 of the huIL-4Ra is important for linking In this study, we have clearly shown that the domain
including the I4R motif can direct CD23 induction (andto both the 4PS/IRS-1 pathway and the gene induction
pathway, recent data suggests that the DNA binding gel shift activity, data not shown) in transfected M12.4.1
cells and that expression of Y497 is required for thisactivity of Stat6, as detected by gel shift assay, is not
dependent on 4PS expression in the 32D cell system effect. Ryan et al. (1996 [this issue of Immunity]) found
that CD23 induction in M12.4.1 is tightly linked to EMSA(Pernis et al., 1995). Recently, it was shown that two
phosphopeptides derived from the STAT domain of the activity containing Stat6. In addition, a region of the
murine CD23 promoter containing a putative Stat6 bind-huIL-4R could block the binding of Stat6 to DNA (Hou
et al., 1994), suggesting that these residues were re- ing site (Kohler and Rieber, 1993; Kotanides and Reich,
1993) was shown to regulate the IL-4-induced transcrip-sponsible for recruiting Stat6 to the activated IL-4 recep-
tor complex; in this assay, phosphopeptides containing tion of a reporter construct (Richards and Katz, 1994).
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(Figure 7). These domains function efficiently in the con-
text of the IL-2 receptor, which shares certain homolo-
gies with the IL-4 receptor, notably an association with
JAK-1 and gc. It remains to be determinedwhether these
sequence motifs will also direct IL-4-function in another
receptor background that is structurally divergent from
the IL-4 receptor and is not, in particular, associated
with members of the Janus kinase family.
Experimental Procedures
Cells and Reagents
The IL-3-dependent myeloid cell line expressing the cDNA encoding
rat IRS-1 (Wang et al., 1993b), 32D-IRS-1 (obtained from Dr. J. H.
Pierce, National Cancer Institute), was maintained in RPMI supple-
mented with glutamine, penicillin±streptomycin, 10% fetal calf se-
rum (C-RPMI), and 10% WEHI-3 conditioned medium. The B cell
lymphoma M12.4.1 (obtained from Dr. R. Asofsky, National Institutes
of Health) was maintained in C-RPMI in the absence of cytokines.
Recombinant muIL-4 expressed in baculovirus was affinity purifiedFigure 7. Y-Containing Sequences within the Cytoplasmic Domain
of the IL-4Ra Convey IL-4-Specific Responses as described (Ohara et al., 1987). Recombinant huIL-2 was a gift
from Dr. S. Rosenberg (National Cancer Institute).A diagram of the signaling pathways activated by transplanted re-
gions of the huIL-4Ra is shown. The domain containing the I4R motif
(amino acids 439±555) is lightly shaded. The domain containing
Construction of Chimeric Receptors
peptide sequence shown to interact with Stat6 (amino acids 558± The IL-4R±IL-2R chimeras weregenerated using a two-step overlap-
657) is hatched. The domain containing the I4R motif can activate ping polymerase chain reaction (PCR) strategy (Higuchi, 1990). For
both the 4PS/IRS-1 pathway and the gene induction pathway. The example, details for the construction of chimera-1 are given. Details
amino acids 558±657 domain strongly activates the gene induction for theother constructs are available on request. Sense oligonucleo-
pathways, but does not affect the 4PS/IRS-1 pathway. The cross- tide (bchim-1) corresponding to the sequence just 59 to the AatII
regulation of signaling function by the two domains at the receptor site of the human IL-2Rb (960 bp) and anti-sense oligonucleotide
level or at the signaling level is indicated by the question marks. (bchim-2) containing sequence derived from the huIL-4R 59 to the
I4R motif (1490 bp) and sequence derived from the IL-2Rb (1343 bp),
were used to amplify a 407 bp fragment from the huIL-2Rb±pME18s
template plasmid (obtained from Dr. W. Leonard, National Heart,Therefore, it is likely that the I4R motif can direct the
Lung, and Blood Institute). We used pfu polymerase (Stratagene,
activation of Stat6 or a protein that is immunologically La Jolla, California) to reduce PCR-generated mutations. Sense oli-
related to the cloned murine Stat6. It is possible that gonucleotide complementary to bchim-2 (bchim-3) and an anti-
Stat6 has different affinities for the different tyrosine sense oligonucleotide derived from huIL-4R sequence 39 to the I4R
motif (1840 bp) and containing translational stop and XbaI sitesresidues of the IL-4R; the interaction of Stat6 with the
(bchim-4) were used to amplify a 360 bp fragment from the huIL-peptide containing Y497 may not have sufficient binding
4R±LTR-2 template plasmid containing cDNA for either wild-type oraffinity to block the DNA binding activity in an in vitro
Y497FhuIL-4R. The two PCR products were gel purified, mixed in
assay. Indeed, the sequence surrounding Y497 is equal proportions, and then used as template for a second PCR
AYRSF, which has some similarity to the prototypic reaction with bchim-1 and bchim-4 as primers. The 767 bp fragment
Stat6 binding site GYKXF. was purified and digested with AatII and XbaI and ligated into the
IL-2Rb±pME18s vector cut with AatII and XbaI. Sequence was veri-Our results support the current hypothesis that spe-
fied by the Sanger dideoxy chain±termination method and analyzedcific tyrosine motifs in the cytoplasmic domains of cyto-
on an automated sequencing machine. The amino acids containedkine receptors, when phosphorylated, physically inter-
within the chimeras are as follows: TRUNC, 2R(1±378); CHIM-1,
act with the SH2 domains of STATs. Several groups 2R(1±378) 4R(439±555); CHIM-2, 2R(1±378) 4R(558±657); CHIM-3,
have found that phosphopeptides derived from receptor 2R(1±378) 4R(439±657). Amino acid numbering begins 11 with the
signal peptide for huIL-4R and with the amino acid after the signalsequences block DNA binding activity of the activated
peptide for huIL-2Rb There are 25 aa in the signal peptide of theSTAT (Greenlund et al., 1994, 1995; Hou et al., 1994; Lin
huIL-4R and 26 for huIL-2Rb.et al., 1995). In addition, it has been shown that the
activation of a particular STAT by a cytokine is deter-
Transfection and Screening of Chimeric Constructsmined by the specific SH2 domains present in the STAT
32D-IRS-1 and M12.4.1 cells were washed two times in phosphate-(Heim et al., 1995) and the presence of the appropriate
buffered saline (PBS) and resuspended in PBS at 6.7 3 107/ml. ForY-containing binding site in the cytokine receptor
each transfection, 2 3 107 cells were used, mixed with 10 mg of
(Greenlund et al., 1995; Schindler et al., 1995). Indeed, chimeric DNA and 1 mg of vector carrying neomycin resistance, and
Stahl et al. (1995) found that the sequence motif YXXQ, subjected to electroporation using a Bio-Rad gene-pulsar set on 200
derived from the cytoplasmic domain of gp130, was V and 960 mFa. After transfection, the cells were cultured overnight in
the appropriate media before selection with 800 mg/ml G418 (Lifesufficient to direct the tyrosine phosphorylation of Stat3
Technologies, Grand Island, New York). Neomycin-resistant wellsin the context of the erythropoietin receptor.
were tested for expression of IL-2Rb by FACS analysis using biotin±Here, we have shown that Y-based sequence motifs
anti-human IL-2Rb (Endogen, Boston, Massachusetts) followed by
found in distinct cytoplasmic domains of the IL-4-Ra strep±avidin±phycoerythrin (Southern Biotechnology, Birmingham,
differentially activate biochemical pathways leading to Alabama). The anti-Fc receptor antibody 2.4G2 was used to block
Fc binding.biological outcomes, cell growth or gene expression
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Cellular Proliferation Assays for the proliferative signal transduction. Proc. Natl. Acad. Sci. USA
92, 5482±5486.For the study of cellular proliferation, the cells were incubated at
5000 cells per well in a final volume of 0.2 ml of complete RPMI in Galizzi, J.-P., Zuber, C.E., Harada, N., Gorman, D.M., Djossou, O.,
the presence or absence of muIL-3 or huIL-2 for 72 hr at 378C. The Kastelein, R., Banchereau, J., Howard, M., and Miyajima, A. (1990).
wells were pulsed with 1 mCi/well [3H]thymidine for the final 4 hr of Molecular cloning of a cDNA encoding the human interleukin-4 re-
culture before harvesting using a Packard harvestor and the Matrix ceptor. Int. Immunol. 2, 669±679.
9600 direct b count system.
Giri, J.G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K.,
Kumaki, S., Namen, A., Park, L.S., Cosman, D., and Anderson, D.
CD23 Induction Assay (1994). Utilization of the b and g chains of the IL-2 receptor by the
M12.4.1 cells expressing the various constructs of the IL-2Rb were novel cytokine IL-15. EMBO J. 13, 2822±2830.
incubated at 1 3 105/ml in C-RPMI in the presence or absence of Goldsmith, M.A., Zu, W., Amaral, M.C., Kuczek, E.S., and Greene,
muIL-4 (5 ng/ml) or huIL-2 (100 U/ml) for 48 hr at 378C. Expression W.C. (1994). The cytoplasmic domain of the interleukin-2 receptor
of murine CD23 was tested by FACS analysis using fluorescein b chains contains both unique and functionally redundant signal
isothiocyanate (FITC)±B3B4 (anti-murine CD23), a gift from Dr. transduction elements. J. Biol. Chem. 269, 14698±14704.
D. H. Conrad (Virginia Commonwealth University), in the presence
Greenlund, A.C., Farrar, M.A., Viviano, B.L., and Schreiber, R.D.of the anti-Fc receptor antibody 2.4G2 to block Fc binding, before
(1994). Ligand induced IFN receptor phosphorylation couples the
analysis on a FACScan (Becton-Dickinson).
receptor to its signal transduction system (p91). EMBO J. 13, 1591±
1600.
Immunoprecipitation and Immunoblotting Greenlund, A.C., Morales, M.O., Viviano, B.L., Yan, H., Krolewski,
Analysis of phosphotyrosine containing proteins was performed as J., and Schreiber, R.D. (1995). Stat recruitment by tyrosine-phos-
previously described (Keegan et al., 1994a). Cells were preincubated phorylated receptors: an ordered,reversible, affinity-drivenprocess.
in RPMI without serum or cytokines for 2 hr at 378C. After washing, Immunity 2, 677±687.
the cells were resuspended in RPMI with 50 mM Na3VO4 and incu- Hatakeyama, M., Mori, H., Doi, T., and Tanaguchi, T. (1989). A re-bated in the presence or absence of muIL-4 (5 ng/ml) or huIL-2 (100
stricted cytoplasmic region of the IL-2 receptor b chain is essentialU/ml) for 10 min at room temperature. The reaction was terminated
for growth signal transduction but not for ligandbinding and internal-by 10-fold dilution in ice-cold PBS containing 100 mM Na3VO4. Cell ization. Cell 59, 837±845.pellets were lysed in HEPES lysis buffer (50 mM HEPES, 150 mM
Heim, M.H., Kerr, I.M., Stark, G.R., and Darnell, J.E., Jr. (1995). Con-NaCl, 0.5% NP-40, 1 mM Na3VO4, NaF, pyrophosphate, 1 mM PMSF,
tribution of STAT SH2 groups to specific interferon signaling by theand protease inhibitor cocktail) and clarified. The soluble fraction
Jak±STAT pathway. Science 267, 1347±1349.was immunoprecipitated with a monoclonal anti-phosphotyrosine
antibody, 4G10, polyclonal anti-p85, or anti-GRB2 (all obtained from Higuchi, R. (1990). Recombinant PCR. In PCR Protocols, M.A. Innis,
UBI, Lake Placid, New York) or rabbit anti-IRS-1 (a gift from Drs. D.H. Gelfand, J.J. Snisky, and T.J. White, eds. (San Diego, California:
L. M. Wang and J. H. Pierce, National Cancer Institute). The precipi- Academic Press, Incorporated), pp. 177±183.
tates were washed three times in lysis buffer and solubilized in SDS Hou, J., Schindler, U., Henzel, W.J., Ho, T.-C., Brasseur, M., and
sample buffer. The samples were separated on a 7.5% SDS± McKnight, S.L. (1994). An interleukin-4-induced transcription factor:
polyacrylamide gel before transfer to PVDF membrane. The mem- IL-4 stat. Science 265, 1701±1706.
branes were blocked with PBS, 3% bovine serum albumin, 0.05%
Idzerda, R.L., March, C.J., Mosley, B., Lyman, S.D., VandenBos, T.,Tween-20. The blots were probed with anti-phosphotyrosine (1 mg/
Gimpel, S.D., Din, W.S., Grabstein, K.H., Widmer, M.B., Park, L.S.,ml). The bound antibody was detected using enhanced chemilumi-
Cosman, D., and Beckmann, M.P. (1990). Human interleukin 4 recep-nescence (Amersham, Arlington, Heights, Illinois). Densitometry was
tor confers biological responsiveness and defines a novel receptorperformed using either the RFLP-scan software from Stratagene
superfamily. J. Exp. Med. 171, 861±873.(Figure 4) or the NIH-Image software (Figure 5).
Ivashkiv, L.B. (1995). Cytokines and STATS: how can signals achieve
specificity? Immunity 3, 1±4.
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